By rray, 31 October, 2023 Exclude Patient Type Detail Header No Detail Type Text Detail Text Don t give palivizumab later in the same RSV season However nbsp If an infant has already received Infants born shortly before and during the RSV season Aim for nirsevimab administration in the 1st wk of life May occur during the birth hospitalization or in the out pt setting Infants w prolonged birth hospitalizations because of prematurity or other ca Infants Infants and children 8 19 mo at increased risk of severe RSV dz Give nirsevimab shortly before the start of the RSV season Nirsevimab may be given to age eligible infants and children who haven t received a dose at any time during the RSV season Second dose Only children who meet high risk criteria should receive 1 dose of nirsevimab 1 dose in their 1st RSV season and 1 dose in their 2nd RSV season Healthy newborns born at the end of RSV season who received nirsevimab around the time of delivery Timing Nirsevimab may be given in most of the continental U S from Oct Mar Because timing of the onset peak and decline of RSV activity may vary administration schedules may be adjusted based on local RSV activity nbsp Tropical climates including southern Coadministration Simultaneous administration of nirsevimab w age appropriate vaccines is recommended nbsp In clinical trials when nirsevimab was administered concomitantly w routine childhood vaccines the safety and reactogenicity profile was similar to w Patient Type Detail Header (Long) If nirsevimab is administered:<sup>3</sup>
